Identification of the Metabolites of Angiotensin II (1-8) in MES-13 Cells by a Simple NanoLC-MS-MS System: A Preliminary Platform

REFERENCES

• Bassett , M. H. , P. C. White , and W. E. Rainey . 2004 . The regulation of aldosterone synthase expression . Mol. Cell Endocrinol. 217 : 67 – 74 .
   PubMed Web of Science ®Google Scholar
• Basso , N. , and N. A. Terragno . 2001 . History about the discovery of the renin-angiotensin system . Hypertension. 38 : 1246 – 1249 .
   PubMed Web of Science ®Google Scholar
• Bujak-Giżycka , B. , J. Madej , P. P. Wolkow , R. Olszanecki , L. Drabik , J. Rutowski , and R. Korbut . 2007 . Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) . J. Physiol. Pharmacol. 58 : 529 – 540 .
   PubMedGoogle Scholar
• Ferrario , C. M. 2006 . Angiotensin-converting enzyme 2 and angiotensin (1-7): An evolving story in cardiovascular regulation . Hypertension. 47 : 515 – 521 .
   PubMed Web of Science ®Google Scholar
• Gammelgaard , I. , S. Wamberg , and P. Bie . 2006 . Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system . Acta Physiol. 188 : 129 – 138 .
   PubMedGoogle Scholar
• Hall , J. E. 2003. Historical perspective of the renin-angiotensin system. Mol. Biotechnol. 24: 27–39.
   PubMed Web of Science ®Google Scholar
• Keidar , S. , M. Kaplan , and A. Gamliel-Lazarovich . 2007 . ACE2 of the heart: From angiotensin I to angiotensin (1-7) . Cardiovasc. Res. 73 : 463 – 469 .
   PubMed Web of Science ®Google Scholar
• Krum , H. , and R. E. Gilbert . 2007 . Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders . J. Hypertens. 25 : 25 – 35 .
   PubMed Web of Science ®Google Scholar
• Lanckmans , K. , S. Sarre , I. Smolders , and Y. Michotte . 2007 . Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometry . Rapid Commun. Mass Spectrom. 21 : 1187 – 1195 .
   PubMedGoogle Scholar
• Lanckmans , K. , B. Stragier , S. Sarre , I. Smolders , and Y. Michotte . 2007 . Nano-LC-MS/MS for the monitoring of angiotensin IV in rat brain microdialysates: Limitations and possibilities . J. Sep. Sci. 30 : 2217 – 2224 .
   PubMedGoogle Scholar
• Lortie , M. , S. Bark , R. Blantz , and V. Hook . 2009 . Detecting low-abundance vasoactive peptides in plasma: Progress toward absolute quantitation using nano liquid chromatography-mass spectrometry . Anal. Biochem. 394 : 164 – 170 .
   PubMedGoogle Scholar
• Lu , C. Y. , and C. H. Feng . 2006 . On-line concentration of neomycin and screening aminoglycosides in milk by short capillary column and tandem mass spectrometry . J. Sep. Sci. 29 : 2143 – 2148 .
   PubMedGoogle Scholar
• Lu , C. Y. , C. Y. Wu , and C. H. Lin . 2007 . Protein identification by syringe pump-driven reversed-phase LC-MS/MS . Anal. Biochem. 368 : 123 – 129 .
   PubMedGoogle Scholar
• Matsui , T. , K. Tamaya , T. Kawasaki , and Y. Osajima . 1999 . Determination of angiotensin metabolites in human plasma by fluorimetric high-performance liquid chromatography using a heart-cut column-switching technique . J. Chromatogr. B Biomed. Sci. Appl. 729 : 89 – 95 .
   PubMedGoogle Scholar
• Mehta , P. K. , and K. K. Griendling . 2007 . Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system . Am. J. Physiol. Cell Physiol. 292 : C82 – 97 .
   PubMed Web of Science ®Google Scholar
• Olszanecki , R. , J. Madej , M. Suski , A. Gebska , B. Bujak-Gizycka , and R. Korbut . 2009 . Angiotensin metabolism in rat stomach wall: Prevalence of angiotensin-(1-7) formation . J. Physiol. Pharmacol. 60 : 191 – 196 .
   PubMed Web of Science ®Google Scholar
• Ostertag , P. , B. Mack , G. Rasp , and K. Hermann . 2002 . Immunocytochemical and biochemical identification of angiotensin II in human nasal tissue . Regul. Pept. 107 : 15 – 21 .
   PubMedGoogle Scholar
• Qu , X. , S. K. Deo , E. Dikici , M. Ensor , M. Poon , and S. Daunert . 2007 . Bioluminescence immunoassay for angiotensin II using aequorin as a label . Anal. Biochem. 371 : 154 – 161 .
   PubMedGoogle Scholar
• Raizada , M. K. , and A. J. Ferreira . 2007 . ACE2: Anew target for cardiovascular disease therapeutics . J. Cardiovasc. Pharmacol. 50 : 112 – 119 .
   PubMedGoogle Scholar
• Re , R. N. 2004 . Tissue renin angiotensin systems . Med. Clin. North. Am. 88 : 19 – 38 .
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega , M. , V. Esteban , and J. Egido . 2007 . The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases . Trends Cardiovasc. Med. 17 : 19 – 25 .
   PubMed Web of Science ®Google Scholar
• Santos , R. A. , and A. J. Ferreira . 2007 . Angiotensin (1-7) and the renin-angiotensin system . Curr. Opin. Nephrol. Hypertens. 16 : 122 – 128 .
   PubMed Web of Science ®Google Scholar
• Savoia , C. , and E. L. Schiffrin . 2006 . Inflammation in hypertension . Curr. Opin. Nephrol. Hypertens. 15 : 152 – 158 .
   PubMed Web of Science ®Google Scholar
• Toda , N. , K. Ayajiki , and T. Okamura . 2007 . Interaction of endothelial nitric oxide and angiotensin in the circulation . Pharmacol. Rev. 59 : 54 – 87 .
   PubMed Web of Science ®Google Scholar
• Zini , S. , M. C. Fournie-Zaluski , E. Chauvel , B. P. Roques , P. Corvol , and C. Llorens-Cortes . 1996 . Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release . Proc. Natl. Acad. Sci. USA 93 : 11968 – 11973 .
   PubMed Web of Science ®Google Scholar